MarketWatch
US · 1 hrs ago
✦ 72◉ Centre
Moderna’s stock has rallied on hantavirus research that is ‘early-stage’ in nature
72Accuracy
0Ratings
0Comments
AI Analysis
Accuracy 72/100
Partisan intensity 35/100
ObjectivePartisan
◉ Centre ✓ Fair headline
Moderna's stock has gained value following announcements about early-stage hantavirus research being conducted as a pre-clinical program with the U.S. Army and a Korean university vaccine center.
Moderna’s stock has rallied on hantavirus research that is ‘early-stage’ in nature
The biotech company a pre-clinical program with the U.S. Army and a vaccine center at a Korean university.
Discussion 0 comments
Sort:
?
No comments yet — be the first to start the discussion!